Modifications to Devices Subject to Premarket Approval (PMA) - The PMA Supplement Decision-Making Process: Guidance for Industry and FDA Staff
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
December 11, 2008
February 8, 2022
2fa147f5-4cd9-4ac0-9ae1-09b62dffa25e
Related Documents
Enforcement Policy for Certain Supplements for Approved Premarket Approval (PMA) or Humanitarian Device Exemption (HDE) Submissions: Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentNovember 2, 2023Center for Devices and Radiological Health
30-Day Notices, 135-Day Premarket Approval (PMA) Supplements and 75-Day Humanitarian Device Exemption (HDE) Supplements for Manufacturing Method or Process Changes: Guidance for Industry and FDA Staff
Guidance DocumentDecember 16, 2019Center for Devices and Radiological Health
Manufacturing Site Change Supplements: Content and Submission: Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentDecember 17, 2018Center for Devices and Radiological Health
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.